For over 50 years, Cobalt-60 has served as a crucial source of gamma radiation, extensively used for sterilizing single-use medical devices. This method has become a dominant sterilization modality due to its effectiveness. However, medical device manufacturers often lack visibility into the Cobalt-60 supply chain and its dynamics, as they typically rely on contract sterilization providers. This lack of transparency can hinder their ability to make informed decisions regarding sterilization modalities.
This webinar delves into the intricacies of the global Cobalt-60 supply chain, elucidating how recent events have influenced both supply and demand. It also highlights Nordion’s strategic initiatives to sustain and expand Cobalt-60 availability, ensuring uninterrupted supply. Additionally, the session provides a comprehensive overview of the gamma sterilization process, emphasizing its reliability, cost-effectiveness, and efficacy. Participants will gain insights into the challenges and opportunities within the Cobalt-60 supply chain, empowering them to make better-informed decisions regarding sterilization modalities.
The presentation also explores the broader implications of gamma radiation sterilization in the healthcare sector, particularly in the context of the COVID-19 pandemic. The pandemic underscored the critical role of a robust medical device supply chain in delivering safe and effective healthcare globally. By attending this webinar, stakeholders will better understand the current and future state of Cobalt-60 supply and the enduring relevance of gamma radiation as a sterilization modality.